Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07370454 · ClinicalTrials.gov registry record
Xpert® Hemorrhagic Fever on the GeneXpert® Edge X System
A clinical trial of Hemorrhagic Fever, sponsored by Cepheid.
- Completed
- Registry status
- 408
- Enrollment target
- 1
- Study location
NCT07370454 is a study of Hemorrhagic Fever that has completed, run by Cepheid. The registered enrollment target is 408 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07370454, a study of Hemorrhagic Fever, has completed, sponsored by Cepheid.
- COMPLETED
- Registry status
- 408 participants
- Enrollment target
- 1
- Study location
Study Summary
A multi-site observation study that was conducted a geographically diverse sites across the United States
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Xpert Hemorrhagic Fever test
Study Locations (1)
Maryland
- USAMRIID - Frederick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 408 participants |
| Start Date | 2025-01-13 |
| Est. Completion | 2025-10-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07370454
The ClinicalTrials.gov registry entry for NCT07370454 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 408 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cepheid, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hemorrhagic Fever appearing as the primary indexed condition, and to 1 intervention - of which Xpert Hemorrhagic Fever test is the first listed.
NCT07370454 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT07370454 about?
NCT07370454 is a clinical study titled "Xpert® Hemorrhagic Fever on the GeneXpert® Edge X System". A multi-site observation study that was conducted a geographically diverse sites across the United States
What is the current status of trial NCT07370454?
This trial is currently completed. The enrollment target is 408 participants. The study started on 2025-01-13. Estimated completion is 2025-10-03.
What conditions does trial NCT07370454 study?
This clinical trial studies the following conditions: Hemorrhagic Fever.
What interventions are being tested in trial NCT07370454?
The interventions under investigation include: Xpert Hemorrhagic Fever test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07370454?
This trial is sponsored by Cepheid, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07370454 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.